Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
CYCLACEL PHARMA (NQ: CYCC)
3.070 USD  UNCHANGED
Official Closing Price  /  Updated: 8:10 PM EDT, May 21, 2013  /  Add to My Watchlist      
View: Quote News Research
All news about CYCLACEL PHARMA
 
< Previous 1 2 3 Next >
Cyclacel Pharmaceuticals Announces Closing of Underwritten Offering
May 21, 2013
from GlobeNewswire News Releases
Stocks to Watch (Newcastle Investment Corp, Oncothyreon Inc, Infinity Pharmaceuticals Inc, Cyclacel Pharmaceuticals Inc)
May 17, 2013
Austin, TX -- (SBWIRE) -- 05/17/2013 -- Jackpotpennystocks.com, an investor research portal specializing in several sectors including biotech and healthcare and tech stocks on the U.S. market, issues... Read More
from SBWire - Latest Press Releases
Free Research Reports on AMD, CYCC, GNK and KSS Issued by the Bedford Report
May 17, 2013
Note to Editors: The Following Is an Investment Opinion Being Issued by the Equity News Circuit Read More
from Marketwired News Releases
Markets Rise On Upbeat Earnings
May 16, 2013
Upbeat earnings lifted the market during the midday with the Dow rising 7 points to 15,283. Nasdaq rose 6 points to 3477. Read More
category Market News
from MarketMinute.com Market Updates
NASDAQ Losers: Security National Financial Corporation, Oncothyreon Inc., Infinity Pharmaceuticals, Inc., Cyclacel Pharmaceuticals, Inc.
May 16, 2013
Huntington Beach, CA -- (SBWIRE) -- 05/16/2013 -- PSPicks.com provides its subscribers with a free newsletter that reports up to the minute information and exclusive charts on cheap, undervalued,... Read More
from SBWire - Latest Press Releases
StreetInsider.com Pre-Open Movers 5/16: (TSLA) (CSCO) (SCTY) Higher; (NQ) (AMD) (CYCC) Lower (more...)
May 16, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8346358 for the full story. Read More
from StreetInsider.com News Articles
Cyclacel (CYCC) Prices 6.67M Common Stock Offering
May 16, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8346214 for the full story. Read More
from StreetInsider.com News Articles
Cyclacel Pharmaceuticals Announces $20 Million Underwritten Offering
May 16, 2013
from GlobeNewswire News Releases
Streetinsider.com After-Hours Movers 05/15: (CSCO) (TSLA) (CBI) Higher; (NQ) (CYCC) (DDR) Lower (more...)
May 15, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8344779 for the full story. Read More
from StreetInsider.com News Articles
Cyclacel Pharmaceuticals (CYCC) Announces Stock Offering
May 15, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8343023 for the full story. Read More
from StreetInsider.com News Articles
Cyclacel Pharmaceuticals Announces Proposed Public Offering of Common Stock
May 15, 2013
Cyclacel Pharmaceuticals, Inc. (Nasdaq: CYCC ) (Nasdaq: CYCCP ) (Cyclacel or the Company), today announced that it is offering to sell, subject to market and other conditions, shares of its common... Read More
category CYCCP , Benzinga , CYCC , and 2 more.
from Latest Articles from Benzinga.com
Cyclacel Pharmaceuticals Announces Proposed Public Offering of Common Stock
May 15, 2013
from GlobeNewswire News Releases
Cyclacel Pharmaceuticals, Inc. (CYCC) Posts Q1 GAAP Loss of $1.18/Share
May 13, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8332042 for the full story. Read More
from StreetInsider.com News Articles
Cyclacel Reports First Quarter 2013 Financial Results
May 13, 2013
Conference Call Scheduled on May 13, 2013 at 4:30 p.m. Eastern Time Read More
from GlobeNewswire News Releases
Cyclacel Pharmaceuticals to Announce Release of First Quarter 2013 Financial Results
May 10, 2013
from GlobeNewswire News Releases
Cyclacel Pharmaceuticals, Inc's 6% Convertible Exchangeable Preferred Stock Shares Cross 8% Yield Mark
May 06, 2013
In trading on Monday, shares of Cyclacel Pharmaceuticals, Inc's 6% Convertible Exchangeable Preferred Stock (CYCCP) were yielding above the 8% mark based on its quarterly dividend (annualized to... Read More
category Stocks
from Market News Video
Cyclacel Reports Updated Phase 2 Survival Data of Sapacitabine for MDS
April 30, 2013
Nearly Doubles Expected Median Survival of Older Patients With MDS Who Failed Front-Line Therapies Read More
from GlobeNewswire News Releases
Cyclacel Pharmaceuticals to Present at the 12th Annual Needham Healthcare Conference
April 23, 2013
from GlobeNewswire News Releases
Reminder: Cyclacel Pharmaceuticals, Inc's 6% Convertible Exchangeable Preferred Stock Goes Ex-Dividend Soon
April 16, 2013
On 4/17/13, Cyclacel Pharmaceuticals, Inc's 6% Convertible Exchangeable Preferred Stock (CYCCP) will trade ex-dividend, for its quarterly dividend of $0.15, payable on 5/1/13. As a percentage of... Read More
category Stocks
from Market News Video
Cyclacel Pharma (CYCC) Issues Encouraging Update on Sapacitabine, Seliciclib Phase 1
April 09, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8242361 for the full story. Read More
from StreetInsider.com News Articles
Combination Potential of Cyclacel's Sapacitabine and Seliciclib Reported at AACR
April 09, 2013
Sequential Treatment Showed Antitumor Activity in Patients With Incurable BRCA-Deficient Cancers Read More
from GlobeNewswire News Releases
Cyclacel Pharma (CYCC) Files $75M Mixed Shelf
April 08, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8239793 for the full story. Read More
from StreetInsider.com News Articles
AACR Press Conference Highlights Combination Potential of Two Cyclacel Drugs
April 08, 2013
Novel Drug Combination Active in Patients With Incurable BRCA-Deficient Cancers Read More
from GlobeNewswire News Releases
Notable Mergers and Acquisitions of the Day 04/04: (NHTB) (CYCC)/(CELG)
April 04, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8233536 for the full story. Read More
from StreetInsider.com News Articles
Cyclacel (CYCC) Enters Patent Sale with Celgene (CELG)
April 04, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8232774 for the full story. Read More
from StreetInsider.com News Articles
Cyclacel Announces Sale of Four Cyclacel Romidepsin-Related Patents to Celgene and Dismissal of All Claims in Their Patent Litigation
April 04, 2013
from GlobeNewswire News Releases
Cyclacel Announces Multiple Abstracts Selected for Presentation at American Association for Cancer Research Annual Meeting
April 03, 2013
from GlobeNewswire News Releases
Cyclacel Pharmaceuticals, Inc. (CYCC) Reports Q4 Loss of $0.59
March 27, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8215567 for the full story. Read More
from StreetInsider.com News Articles
Cyclacel Pharmaceuticals Reports Fourth Quarter and Full Year 2012 Financial Results
March 27, 2013
Conference Call Scheduled March 27, 2013 at 4:30 p.m. Eastern Time Read More
from GlobeNewswire News Releases
Wednesday – Worries About Europe Weigh
March 27, 2013
category Market/Outlook , Wall/Street/Preview , Market/Outlook/2013/Q1
from Wall Street Greek
< Previous 1 2 3 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here